Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
Verlagsversion
DOI
PMC
 |
Free journal |
|
möglich sobald bei der ZB eingereicht worden ist.
Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategy.
World J. Virol. 11, 204-207 (2022)
Patients with lymphoid malignancies are at a higher risk of coronavirus disease 2019 (COVID-19) infection due to their immunocompromised state and results in higher mortality rates in these patients. Anti-CD 20 therapy is one of the leading causes of immunosuppression that worsens in COVID-19 cases. COVID-19 vaccines, on the other hand, appear to be less beneficial to these patients. App-ropriate treatment and recommendations are required for these COVID-19 patients with lymphoid malignancies.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Letter to the Editor
Schlagwörter
Covid-19 ; Immuno-suppression ; Lymphoid Malignancy ; Lymphoma ; Vaccination
ISSN (print) / ISBN
2220-3249
e-ISSN
2220-3249
Zeitschrift
World Journal of Virology
Quellenangaben
Band: 11,
Heft: 4,
Seiten: 204-207
Verlag
Baishideng Publ.
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Lung Health and Immunity (LHI)